Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Arrhythmias

  Free Subscription


Articles published in Stroke

Retrieve available abstracts of 87 articles:
HTML format
Text format



Single Articles


    November 2017
  1. YAMADA S, Lin CY, Chang SL, Chao TF, et al
    Risk of Stroke in Patients With Short-Run Atrial Tachyarrhythmia.
    Stroke. 2017 Nov 16. pii: STROKEAHA.117.018475.
    PubMed     Text format     Abstract available


  2. SHOAMANESH A, Charidimou A, Sharma M, Hart RG, et al
    Should Patients With Ischemic Stroke or Transient Ischemic Attack With Atrial Fibrillation and Microbleeds be Anticoagulated?
    Stroke. 2017 Nov 7. pii: STROKEAHA.117.018467. doi: 10.1161/STROKEAHA.117.018467
    PubMed     Text format    


    October 2017
  3. VINEREANU D, Lopes RD, Mulder H, Gersh BJ, et al
    Echocardiographic Risk Factors for Stroke and Outcomes in Patients With Atrial Fibrillation Anticoagulated With Apixaban or Warfarin.
    Stroke. 2017 Oct 31. pii: STROKEAHA.117.017574.
    PubMed     Text format     Abstract available


  4. CHA MJ, Choi EK, Han KD, Lee SR, et al
    Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Asian Patients With Atrial Fibrillation.
    Stroke. 2017 Oct 3. pii: STROKEAHA.117.018773. doi: 10.1161/STROKEAHA.117.018773
    PubMed     Text format     Abstract available


    September 2017
  5. KIM TH, Yang PS, Kim D, Yu HT, et al
    CHA2DS2-VASc Score for Identifying Truly Low-Risk Atrial Fibrillation for Stroke: A Korean Nationwide Cohort Study.
    Stroke. 2017 Sep 22. pii: STROKEAHA.117.018551.
    PubMed     Text format     Abstract available


  6. HILKENS NA, Algra A, Greving JP
    Predicting Major Bleeding in Ischemic Stroke Patients With Atrial Fibrillation.
    Stroke. 2017 Sep 20. pii: STROKEAHA.117.019183.
    PubMed     Text format     Abstract available


  7. SELIM M, Diener HC
    Atrial Fibrillation and Microbleeds.
    Stroke. 2017 Sep 15. pii: STROKEAHA.117.017085.
    PubMed     Text format    


  8. GOLDSTEIN LB
    Anticoagulation in Patients With Atrial Fibrillation in the Setting of Prior Hemorrhage: An Ongoing Dilemma.
    Stroke. 2017 Sep 15. pii: STROKEAHA.117.017082.
    PubMed     Text format    


  9. THIJS V
    Atrial Fibrillation Detection: Fishing for An Irregular Heartbeat Before and After Stroke.
    Stroke. 2017 Sep 15. pii: STROKEAHA.117.017083.
    PubMed     Text format    


  10. YAGHI S, Kamel H
    Stratifying Stroke Risk in Atrial Fibrillation: Beyond Clinical Risk Scores.
    Stroke. 2017 Sep 15. pii: STROKEAHA.117.017084.
    PubMed     Text format    


  11. DRABIK L, Wolkow P, Undas A
    Fibrin Clot Permeability as a Predictor of Stroke and Bleeding in Anticoagulated Patients With Atrial Fibrillation.
    Stroke. 2017 Sep 13. pii: STROKEAHA.117.018143.
    PubMed     Text format     Abstract available


  12. BISSON A, Clementy N, Bodin A, Angoulvant D, et al
    Relationship of Preexisting Cardiovascular Comorbidities to Newly Diagnosed Atrial Fibrillation After Ischemic Stroke.
    Stroke. 2017 Sep 1. pii: STROKEAHA.117.018251. doi: 10.1161/STROKEAHA.117.018251
    PubMed     Text format     Abstract available


    August 2017
  13. YOON CY, Noh J, Jhee JH, Chang TI, et al
    Warfarin Use in Patients With Atrial Fibrillation Undergoing Hemodialysis: A Nationwide Population-Based Study.
    Stroke. 2017 Aug 11. pii: STROKEAHA.117.017114.
    PubMed     Text format     Abstract available


  14. THOREN M, Azevedo E, Dawson J, Egido JA, et al
    Predictors for Cerebral Edema in Acute Ischemic Stroke Treated With Intravenous Thrombolysis.
    Stroke. 2017 Aug 3. pii: STROKEAHA.117.018223. doi: 10.1161/STROKEAHA.117.018223
    PubMed     Text format     Abstract available



  15. Correction to: Ischemic Stroke in Nonvalvular Atrial Fibrillation at Warfarin Initiation: Assessment via a Large Insurance Database.
    Stroke. 2017;48:e239.
    PubMed     Text format    


    July 2017
  16. NTAIOS G, Papavasileiou V, Makaritsis K, Vemmos K, et al
    Real-World Setting Comparison of Nonvitamin-K Antagonist Oral Anticoagulants Versus Vitamin-K Antagonists for Stroke Prevention in Atrial Fibrillation: A Systematic Review and Meta-Analysis.
    Stroke. 2017 Jul 17. pii: STROKEAHA.117.017549.
    PubMed     Text format     Abstract available


  17. MAZUREK M, Shantsila E, Lane DA, Wolff A, et al
    Secondary Versus Primary Stroke Prevention in Atrial Fibrillation: Insights From the Darlington Atrial Fibrillation Registry.
    Stroke. 2017 Jul 5. pii: STROKEAHA.116.016146. doi: 10.1161/STROKEAHA.116.016146
    PubMed     Text format     Abstract available


    June 2017
  18. HERNANDEZ I, Saba S, Zhang Y
    Geographic Variation in the Use of Oral Anticoagulation Therapy in Stroke Prevention in Atrial Fibrillation.
    Stroke. 2017 Jun 27. pii: STROKEAHA.117.017683.
    PubMed     Text format     Abstract available


  19. COLEMAN CI, Peacock WF, Bunz TJ, Alberts MJ, et al
    Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation and Previous Stroke or Transient Ischemic Attack.
    Stroke. 2017 Jun 27. pii: STROKEAHA.117.017474.
    PubMed     Text format     Abstract available


  20. FLINT AC, Conell C, Ren X, Kamel H, et al
    Statin Adherence Is Associated With Reduced Recurrent Stroke Risk in Patients With or Without Atrial Fibrillation.
    Stroke. 2017 Jun 8. pii: STROKEAHA.117.017343. doi: 10.1161/STROKEAHA.117.017343
    PubMed     Text format     Abstract available


    May 2017
  21. APPELROS P, Farahmand B, Terent A, Asberg S, et al
    To Treat or Not to Treat: Anticoagulants as Secondary Preventives to the Oldest Old With Atrial Fibrillation.
    Stroke. 2017 May 9. pii: STROKEAHA.117.016902. doi: 10.1161/STROKEAHA.117.016902
    PubMed     Text format     Abstract available


  22. LUBITZ SA, Parsons OE, Anderson CD, Benjamin EJ, et al
    Atrial Fibrillation Genetic Risk and Ischemic Stroke Mechanisms.
    Stroke. 2017 May 3. pii: STROKEAHA.116.016198. doi: 10.1161/STROKEAHA.116.016198
    PubMed     Text format     Abstract available


    April 2017
  23. KIM TH, Yang PS, Uhm JS, Kim JY, et al
    CHA2DS2-VASc Score (Congestive Heart Failure, Hypertension, Age >/=75 [Doubled], Diabetes Mellitus, Prior Stroke or Transient Ischemic Attack [Doubled], Vascular Disease, Age 65-74, Female) for Stroke in Asian Patients With Atrial Fibrillation: A K
    Stroke. 2017 Apr 28. pii: STROKEAHA.117.016926.
    PubMed     Text format     Abstract available


  24. MACHADO-ALBA JE, Arias-Jaramillo DR, Gaviria-Mendoza A
    Letter by Machado-Alba et al Regarding Article, "Rivaroxaban Versus Dabigatran or Warfarin in Real-World Studies of Stroke Prevention in Atrial Fibrillation: Systematic Review and Meta-Analysis".
    Stroke. 2017 Apr 28. pii: STROKEAHA.117.017375.
    PubMed     Text format    


  25. BAI Y, Shantsila A, Lip GYH
    Response by Bai et al to Letter Regarding Article, "Rivaroxaban Versus Dabigatran or Warfarin in Real-World Studies of Stroke Prevention in Atrial Fibrillation: Systematic Review and Meta-Analysis".
    Stroke. 2017 Apr 28. pii: STROKEAHA.117.017460.
    PubMed     Text format    


  26. TEPPER PG, Liu X, Hamilton M, Mardekian J, et al
    Ischemic Stroke in Nonvalvular Atrial Fibrillation at Warfarin Initiation: Assessment via a Large Insurance Database.
    Stroke. 2017 Apr 26. pii: STROKEAHA.116.015535.
    PubMed     Text format     Abstract available


  27. LUBITZ SA, Seshadri S, Benjamin EJ
    Response by Lubitz et al to Letter Regarding Article, "Stroke as the Initial Manifestation of Atrial Fibrillation: The Framingham Heart Study".
    Stroke. 2017 Apr 17. pii: STROKEAHA.117.017108.
    PubMed     Text format    


  28. SPOSATO LA, Fridman S, Saposnik G
    Letter by Sposato et al Regarding Article, "Stroke as the Initial Manifestation of Atrial Fibrillation: The Framingham Heart Study".
    Stroke. 2017 Apr 17. pii: STROKEAHA.117.017066.
    PubMed     Text format    


  29. COLL-VINENT B, Martin A, Sanchez J, Tamargo J, et al
    Benefits of Emergency Departments' Contribution to Stroke Prophylaxis in Atrial Fibrillation: The EMERG-AF Study (Emergency Department Stroke Prophylaxis and Guidelines Implementation in Atrial Fibrillation).
    Stroke. 2017 Apr 7. pii: STROKEAHA.116.014855. doi: 10.1161/STROKEAHA.116.014855
    PubMed     Text format     Abstract available


    March 2017
  30. NIELSEN PB, Johnsen SP
    Letter by Nielsen and Johnsen Regarding Article, "Optimal Timing of Anticoagulant Treatment After Intracerebral Hemorrhage in Patients With Atrial Fibrillation".
    Stroke. 2017 Mar 10. pii: STROKEAHA.117.016747.
    PubMed     Text format    


  31. PENNLERT J, Asplund K, Eriksson M
    Response by Pennlert et al to Letter Regarding Article, "Optimal Timing of Anticoagulant Treatment After Intracerebral Hemorrhage in Patients With Atrial Fibrillation".
    Stroke. 2017 Mar 10. pii: STROKEAHA.117.016838.
    PubMed     Text format    


  32. PROIETTI M, Guiducci E, Cheli P, Lip GY, et al
    Is There an Obesity Paradox for Outcomes in Atrial Fibrillation? A Systematic Review and Meta-Analysis of Non-Vitamin K Antagonist Oral Anticoagulant Trials.
    Stroke. 2017 Mar 6. pii: STROKEAHA.116.015984. doi: 10.1161/STROKEAHA.116.015984
    PubMed     Text format     Abstract available


  33. SCHWAMMENTHAL Y, Tsabari R, Orion D, Merzlyak O, et al
    Shifting Perceptions of Risk and Reward: Use of Anticoagulation in Patients With Acute Brain Ischemia and Atrial Fibrillation: Nine-Year Data From a National Acute Stroke Registry (National Acute Stroke Israeli Survey [NASIS]).
    Stroke. 2017 Mar 3. pii: STROKEAHA.116.015776. doi: 10.1161/STROKEAHA.116.015776
    PubMed     Text format     Abstract available


    February 2017
  34. BAI Y, Deng H, Shantsila A, Lip GY, et al
    Rivaroxaban Versus Dabigatran or Warfarin in Real-World Studies of Stroke Prevention in Atrial Fibrillation: Systematic Review and Meta-Analysis.
    Stroke. 2017 Feb 17. pii: STROKEAHA.116.016275.
    PubMed     Text format     Abstract available


  35. PACIARONI M, Agnelli G, Caso V, Tsivgoulis G, et al
    Prediction of Early Recurrent Thromboembolic Event and Major Bleeding in Patients With Acute Stroke and Atrial Fibrillation by a Risk Stratification Schema: The ALESSA Score Study.
    Stroke. 2017 Feb 9. pii: STROKEAHA.116.015770. doi: 10.1161/STROKEAHA.116.015770
    PubMed     Text format     Abstract available


  36. MATTSSON N, Kumarathurai P, Larsen BS, Nielsen OW, et al
    Mild Hypokalemia and Supraventricular Ectopy Increases the Risk of Stroke in Community-Dwelling Subjects.
    Stroke. 2017 Feb 7. pii: STROKEAHA.116.015439. doi: 10.1161/STROKEAHA.116.015439
    PubMed     Text format     Abstract available


  37. LANG C, Seyfang L, Ferrari J, Gattringer T, et al
    Do Women With Atrial Fibrillation Experience More Severe Strokes? Results From the Austrian Stroke Unit Registry.
    Stroke. 2017 Feb 1. pii: STROKEAHA.116.015900. doi: 10.1161/STROKEAHA.116.015900
    PubMed     Text format     Abstract available


    January 2017
  38. HOLT TA, Dalton A, Marshall T, Fay M, et al
    Automated Software System to Promote Anticoagulation and Reduce Stroke Risk: Cluster-Randomized Controlled Trial.
    Stroke. 2017 Jan 24. pii: STROKEAHA.116.015468.
    PubMed     Text format     Abstract available


  39. LUBITZ SA, Yin X, McManus DD, Weng LC, et al
    Stroke as the Initial Manifestation of Atrial Fibrillation: The Framingham Heart Study.
    Stroke. 2017 Jan 12. pii: STROKEAHA.116.015071.
    PubMed     Text format     Abstract available


    December 2016
  40. PENNLERT J, Overholser R, Asplund K, Carlberg B, et al
    Optimal Timing of Anticoagulant Treatment After Intracerebral Hemorrhage in Patients With Atrial Fibrillation.
    Stroke. 2016 Dec 20. pii: STROKEAHA.116.014643.
    PubMed     Text format     Abstract available


  41. HERNANDEZ I, Zhang Y, Brooks MM, Chin PK, et al
    Anticoagulation Use and Clinical Outcomes After Major Bleeding on Dabigatran or Warfarin in Atrial Fibrillation.
    Stroke. 2016 Dec 1. pii: STROKEAHA.116.015150.
    PubMed     Text format     Abstract available


    October 2016
  42. ACAMPA M, Lazzerini PE, Martini G
    Letter by Acampa et al Regarding Article, "Underutilization of Ambulatory ECG Monitoring After Stroke and Transient Ischemic Attack: Missed Opportunities for Atrial Fibrillation Detection".
    Stroke. 2016 Oct 18. pii: STROKEAHA.116.014947.
    PubMed     Text format    


  43. BONDE AN, Lip GY, Kamper AL, Fosbol EL, et al
    Renal Function and the Risk of Stroke and Bleeding in Patients With Atrial Fibrillation: An Observational Cohort Study.
    Stroke. 2016 Oct 6. pii: STROKEAHA.116.014422.
    PubMed     Text format     Abstract available


  44. WOOD AD, Mannu GS, Clark AB, Tiamkao S, et al
    Rheumatic Mitral Valve Disease Is Associated With Worse Outcomes in Stroke: A Thailand National Database Study.
    Stroke. 2016 Oct 4. pii: STROKEAHA.116.014512.
    PubMed     Text format     Abstract available


    September 2016
  45. CHAO TF, Lip GY, Liu CJ, Tuan TC, et al
    Validation of a Modified CHA2DS2-VASc Score for Stroke Risk Stratification in Asian Patients With Atrial Fibrillation: A Nationwide Cohort Study.
    Stroke. 2016 Sep 13. pii: STROKEAHA.116.013880.
    PubMed     Text format     Abstract available


    August 2016
  46. BUCHWALD F, Norrving B, Petersson J
    Atrial Fibrillation in Transient Ischemic Attack Versus Ischemic Stroke: A Swedish Stroke Register (Riksstroke) Study.
    Stroke. 2016 Aug 25. pii: STROKEAHA.116.013988.
    PubMed     Text format     Abstract available


  47. KOGA M, Yoshimura S, Hasegawa Y, Shibuya S, et al
    Higher Risk of Ischemic Events in Secondary Prevention for Patients With Persistent Than Those With Paroxysmal Atrial Fibrillation.
    Stroke. 2016 Aug 16. pii: STROKEAHA.116.013746.
    PubMed     Text format     Abstract available


  48. FAUCHIER L, Bisson A, Lip GY
    Response by Fauchier et al to Letter Regarding Article, "Should Atrial Fibrillation Patients With Only 1 Nongender-Related CHA2DS2-VASc Risk Factor Be Anticoagulated?"
    Stroke. 2016 Aug 11. pii: STROKEAHA.116.014619.
    PubMed     Text format    


  49. ZHANG H, Hao YG, Xu G
    Letter by Zhang et al Regarding Article, "Should Atrial Fibrillation Patients With Only 1 Nongender-Related CHA2DS2-VASc Risk Factor Be Anticoagulated?"
    Stroke. 2016 Aug 11. pii: STROKEAHA.116.014301.
    PubMed     Text format    


  50. PERERA KS, Vanassche T, Bosch J, Swaminathan B, et al
    Global Survey of the Frequency of Atrial Fibrillation-Associated Stroke: Embolic Stroke of Undetermined Source Global Registry.
    Stroke. 2016 Aug 9. pii: STROKEAHA.116.013378.
    PubMed     Text format     Abstract available


    July 2016
  51. YONG JH, Thavorn K, Hoch JS, Mamdani M, et al
    Potential Cost-Effectiveness of Ambulatory Cardiac Rhythm Monitoring After Cryptogenic Stroke.
    Stroke. 2016 Jul 28. pii: STROKEAHA.115.011979.
    PubMed     Text format     Abstract available


  52. EDWARDS JD, Kapral MK, Fang J, Saposnik G, et al
    Underutilization of Ambulatory ECG Monitoring After Stroke and Transient Ischemic Attack: Missed Opportunities for Atrial Fibrillation Detection.
    Stroke. 2016 Jul 12. pii: STROKEAHA.115.012195.
    PubMed     Text format     Abstract available


  53. ROST NS, Giugliano RP, Ruff CT, Murphy SA, et al
    Outcomes With Edoxaban Versus Warfarin in Patients With Previous Cerebrovascular Events: Findings From Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48.
    Stroke. 2016 Jul 7. pii: STROKEAHA.116.013540.
    PubMed     Text format     Abstract available


    June 2016
  54. WINTERHOLLER M, Hollander C, Kerling F, Weber I, et al
    Stroke in Duchenne Muscular Dystrophy: A Retrospective Longitudinal Study in 54 Patients.
    Stroke. 2016 Jun 28. pii: STROKEAHA.116.013678.
    PubMed     Text format     Abstract available


  55. STANNE TM, Aberg ND, Nilsson S, Jood K, et al
    Low Circulating Acute Brain-Derived Neurotrophic Factor Levels Are Associated With Poor Long-Term Functional Outcome After Ischemic Stroke.
    Stroke. 2016 Jun 14. pii: STROKEAHA.115.012383.
    PubMed     Text format     Abstract available


  56. BERROUSCHOT J, Stoll A, Hogh T, Eschenfelder CC, et al
    Intravenous Thrombolysis With Recombinant Tissue-Type Plasminogen Activator in a Stroke Patient Receiving Dabigatran Anticoagulant After Antagonization With Idarucizumab.
    Stroke. 2016 Jun 14. pii: STROKEAHA.116.013550.
    PubMed     Text format     Abstract available


  57. NIELSEN PB, Larsen TB, Lip GY
    Letter by Nielsen et al Regarding Article, "Ischemic Stroke Risk in Patients With Atrial Fibrillation and CHA2DS2-VASc Score of 1: Systematic Review and Meta-Analysis".
    Stroke. 2016 Jun 9. pii: STROKEAHA.116.013672.
    PubMed     Text format    


  58. CHANG SS, Dong JZ, Ma CS, Du X, et al
    Current Status and Time Trends of Oral Anticoagulation Use Among Chinese Patients With Nonvalvular Atrial Fibrillation: The Chinese Atrial Fibrillation Registry Study.
    Stroke. 2016 Jun 9. pii: STROKEAHA.116.012988.
    PubMed     Text format     Abstract available


  59. JOUNDI RA, Cipriano LE, Sposato LA, Saposnik G, et al
    Response to Letter Regarding Article, "Ischemic Stroke Risk in Patients With Atrial Fibrillation and CHA2DS2-VASc Score of 1: Systematic Review and Meta-Analysis".
    Stroke. 2016 Jun 9. pii: STROKEAHA.116.013721.
    PubMed     Text format    


  60. PANDEY A, Patel MR, Willis B, Gao A, et al
    Association Between Midlife Cardiorespiratory Fitness and Risk of Stroke: The Cooper Center Longitudinal Study.
    Stroke. 2016 Jun 9. pii: STROKEAHA.115.011532.
    PubMed     Text format     Abstract available


  61. STOKER TB, Evans NR
    Managing Risk After Intracerebral Hemorrhage in Concomitant Atrial Fibrillation and Cerebral Amyloid Angiopathy.
    Stroke. 2016 Jun 7. pii: STROKEAHA.116.013323.
    PubMed     Text format    


  62. BEKWELEM W, Jensen PN, Norby FL, Soliman EZ, et al
    Carotid Atherosclerosis and Stroke in Atrial Fibrillation: The Atherosclerosis Risk in Communities Study.
    Stroke. 2016;47:1643-6.
    PubMed     Text format     Abstract available


  63. HENNINGER N, Goddeau RP Jr, Karmarkar A, Helenius J, et al
    Atrial Fibrillation Is Associated With a Worse 90-Day Outcome Than Other Cardioembolic Stroke Subtypes.
    Stroke. 2016;47:1486-92.
    PubMed     Text format     Abstract available


    May 2016
  64. FAUCHIER L, Clementy N, Bisson A, Ivanes F, et al
    Should Atrial Fibrillation Patients With Only 1 Nongender-Related CHA2DS2-VASc Risk Factor Be Anticoagulated?
    Stroke. 2016 May 26. pii: STROKEAHA.116.013253.
    PubMed     Text format     Abstract available


  65. GIOIA LC, Kate M, Sivakumar L, Hussain D, et al
    Early Rivaroxaban Use After Cardioembolic Stroke May Not Result in Hemorrhagic Transformation: A Prospective Magnetic Resonance Imaging Study.
    Stroke. 2016 May 24. pii: STROKEAHA.116.013491.
    PubMed     Text format     Abstract available


  66. YOO J, Song D, Baek JH, Kim YD, et al
    Poor Outcome of Stroke Patients With Atrial Fibrillation in the Presence of Coexisting Spontaneous Echo Contrast.
    Stroke. 2016 May 17. pii: STROKEAHA.116.013351.
    PubMed     Text format     Abstract available


  67. WERRING DJ, Wilson D, Marti-Fabregas J
    Letter by Werring et al Regarding Article, "Embolic Stroke, Atrial Fibrillation, and Microbleeds: Is There a Role for Anticoagulation?"
    Stroke. 2016 May 3. pii: STROKEAHA.116.013530.
    PubMed     Text format    


    April 2016
  68. SENOO K, Lip GY
    Female Sex, Time in Therapeutic Range, and Clinical Outcomes in Atrial Fibrillation Patients Taking Warfarin.
    Stroke. 2016 Apr 28. pii: STROKEAHA.116.013173.
    PubMed     Text format     Abstract available


  69. SHAH A, Shewale A, Hayes CJ, Martin BC, et al
    Cost Effectiveness of Oral Anticoagulants for Ischemic Stroke Prophylaxis Among Nonvalvular Atrial Fibrillation Patients.
    Stroke. 2016 Apr 21. pii: STROKEAHA.115.012325.
    PubMed     Text format     Abstract available


    March 2016
  70. JOUNDI RA, Cipriano LE, Sposato LA, Saposnik G, et al
    Ischemic Stroke Risk in Patients With Atrial Fibrillation and CHA2DS2-VASc Score of 1: Systematic Review and Meta-Analysis.
    Stroke. 2016 Mar 29. pii: STROKEAHA.115.012609.
    PubMed     Text format     Abstract available


  71. RIZOS T, Veltkamp R
    Response to Letter Regarding Article, "Preexisting Heart Disease Underlies Newly Diagnosed Atrial Fibrillation After Acute Ischemic Stroke".
    Stroke. 2016 Mar 24. pii: STROKEAHA.116.013108.
    PubMed     Text format    


  72. DOGANAY F, Katlandur H, Ozdil H
    Letter by Doganay et al Regarding Article, "Preexisting Heart Disease Underlies Newly Diagnosed Atrial Fibrillation After Acute Ischemic Stroke".
    Stroke. 2016 Mar 24. pii: STROKEAHA.116.013058.
    PubMed     Text format    


  73. HARUKI S, Minami Y, Hagiwara N
    Stroke and Embolic Events in Hypertrophic Cardiomyopathy: Risk Stratification in Patients Without Atrial Fibrillation.
    Stroke. 2016 Mar 3. pii: STROKEAHA.115.012130.
    PubMed     Text format     Abstract available


  74. DIENER HC, Selim MH, Molina CA, Greenberg SM, et al
    Embolic Stroke, Atrial Fibrillation, and Microbleeds: Is There a Role for Anticoagulation?
    Stroke. 2016;47:904-7.
    PubMed     Text format    


    February 2016
  75. VESTERGAARD AS, Skjoth F, Lip GY, Larsen TB, et al
    Effect of Anticoagulation on Hospitalization Costs After Intracranial Hemorrhage in Atrial Fibrillation: A Registry Study.
    Stroke. 2016 Feb 16. pii: STROKEAHA.115.012338.
    PubMed     Text format     Abstract available


    January 2016
  76. ALLENDE M, Molina E, Gonzalez-Porras JR, Toledo E, et al
    Short Leukocyte Telomere Length Is Associated With Cardioembolic Stroke Risk in Patients With Atrial Fibrillation.
    Stroke. 2016 Jan 19. pii: STROKEAHA.115.011837.
    PubMed     Text format     Abstract available


  77. KAMEL H, Okin PM, Elkind MS, Iadecola C, et al
    Atrial Fibrillation and Mechanisms of Stroke: Time for a New Model.
    Stroke. 2016 Jan 19. pii: STROKEAHA.115.012004.
    PubMed     Text format    


  78. RIZOS T, Horstmann S, Dittgen F, Tager T, et al
    Preexisting Heart Disease Underlies Newly Diagnosed Atrial Fibrillation After Acute Ischemic Stroke.
    Stroke. 2016 Jan 7. pii: STROKEAHA.115.011465.
    PubMed     Text format     Abstract available


  79. PASSMAN R, Bernstein RA
    New Appraisal of Atrial Fibrillation Burden and Stroke Prevention.
    Stroke. 2016 Jan 5. pii: STROKEAHA.115.009930.
    PubMed     Text format    


  80. CHAN YH, Yen KC, See LC, Chang SH, et al
    Cardiovascular, Bleeding, and Mortality Risks of Dabigatran in Asians With Nonvalvular Atrial Fibrillation.
    Stroke. 2016 Jan 5. pii: STROKEAHA.115.011476.
    PubMed     Text format     Abstract available


    December 2015
  81. YANG X, Li Z, Zhao X, Wang C, et al
    Use of Warfarin at Discharge Among Acute Ischemic Stroke Patients With Nonvalvular Atrial Fibrillation in China.
    Stroke. 2015 Dec 22. pii: STROKEAHA.115.011833.
    PubMed     Text format     Abstract available


  82. SENOO K, Lip GY
    Body Mass Index and Adverse Outcomes in Elderly Patients With Atrial Fibrillation: The AMADEUS Trial.
    Stroke. 2015 Dec 1. pii: STROKEAHA.115.011876.
    PubMed     Text format     Abstract available


    November 2015
  83. NADKARNI GN, Patel AA, Konstantinidis I, Mahajan A, et al
    Dialysis Requiring Acute Kidney Injury in Acute Cerebrovascular Accident Hospitalizations.
    Stroke. 2015;46:3226-31.
    PubMed     Text format     Abstract available


    October 2015
  84. YAGHI S, Song C, Gray WA, Furie KL, et al
    Left Atrial Appendage Function and Stroke Risk.
    Stroke. 2015 Oct 27. pii: STROKEAHA.115.011273.
    PubMed     Text format    


    September 2015
  85. KAMEL H, Hunter M, Moon YP, Yaghi S, et al
    Electrocardiographic Left Atrial Abnormality and Risk of Stroke: Northern Manhattan Study.
    Stroke. 2015 Sep 22. pii: STROKEAHA.115.009989.
    PubMed     Text format     Abstract available


  86. SCRUTINIO D, Monitillo V, Guida P, Nardulli R, et al
    Functional Gain After Inpatient Stroke Rehabilitation: Correlates and Impact on Long-Term Survival.
    Stroke. 2015 Sep 3. pii: STROKEAHA.115.010440.
    PubMed     Text format     Abstract available


    August 2015
  87. NORRVING B, Bray BD, Asplund K, Heuschmann P, et al
    Cross-National Key Performance Measures of the Quality of Acute Stroke Care in Western Europe.
    Stroke. 2015 Aug 11. pii: STROKEAHA.115.008811.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Arrhythmias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: